Associated Papers
Pharmacoproteogenomic approach identifies on-target kinase inhibitors for cancer drug repositioning.
Noguchi R et al.
In Vitro Cellular & Developmental Biology. Animal, 2024
Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination.
Lawrence-Paul MR et al.
Genome Medicine, 2024
38321573 (PubMed )
Supplement: 13073_2024_1293_MOESM2_ESM.xlsx › MetSpec_WES_mutations
Assessment of aggressive bladder cancer mutations in plasma cell-free DNA.
Carrasco R et al.
Frontiers in Oncology, 2023
38098507 (PubMed )
Supplement: DataSheet_3.xlsx › Pt_1
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy.
Neron M et al.
Journal of Personalized Medicine, 2022
35629078 (PubMed )
Supplement: jpm-12-00655-s001.zip › Supplementary_tables__MC20220419.xlsx › Table_S4
Select a paper to view details